Netherlands Comprehensive Cancer Organisation (2023) The Netherlands Cancer Registry data & figures application [cited 2023 10 July]. Available from: https://iknl.nl/nkr-cijfers?lang%7Clanguage=en
Statistics Netherlands (2023) StatLine, Population dynamics; month and year [Available from: https://opendata.cbs.nl/statline/#/CBS/en/dataset/83474ENG/table?ts=1616407710127
Gawrieh S, Dakhoul L, Miller E, Scanga A, deLemos A, Kettler C, et al. Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study. Aliment Pharmacol Ther. 2019;50(7):809–21.
Article CAS PubMed Google Scholar
Yen YH, Cheng YF, Wang JH, Lin CC, Wang CC. Characteristics and etiologies of hepatocellular carcinoma in patients without cirrhosis: When East meets West. PLoS ONE. 2021;16(1):e0244939.
Article CAS PubMed PubMed Central Google Scholar
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236.
Singal AG, Llovet JM, Yarchoan M, Mehta N, Heimbach JK, Dawson LA, Taddei TH. AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023;78(6):1922–65.
Nadarevic T, Colli A, Giljaca V, Fraquelli M, Casazza G, Manzotti C, et al. Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. Cochrane Database Syst Rev. 2022;5(5):cd014798.
Nadarevic T, Giljaca V, Colli A, Fraquelli M, Casazza G, Miletic D, et al. Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. Cochrane Database Syst Rev. 2021;10(10):cd013362.
Kim SE, Lee HC, Shim JH, Park HJ, Kim KM, Kim PN, et al. Noninvasive diagnostic criteria for hepatocellular carcinoma in hepatic masses >2 cm in a hepatitis B virus-endemic area. Liver Int. 2011;31(10):1468–76.
Article CAS PubMed Google Scholar
Lin MT, Wang CC, Cheng YF, Eng HL, Yen YH, Tsai MC, et al. Comprehensive comparison of multiple-detector computed tomography and dynamic magnetic resonance imaging in the diagnosis of hepatocellular carcinoma with varying degrees of fibrosis. PLoS ONE. 2016;11(11):e0166157.
Article PubMed PubMed Central Google Scholar
Fischer MA, Raptis DA, Donati OF, Hunziker R, Schade E, Sotiropoulos GC, et al. MR imaging features for improved diagnosis of hepatocellular carcinoma in the non-cirrhotic liver: multi-center evaluation. Eur J Radiol. 2015;84(10):1879–87.
Article CAS PubMed Google Scholar
Lefebvre C, Glanville J, Briscoe S, Featherstone R, Littlewood A, Marshall C, et al. ( 2023) Chapter 4: Searching for and selecting studies. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions version 63 (updated February 2022): Cochrane
Vogel A, Cervantes A, Chau I, Daniele B, Llovet JM, Meyer T, Martinelli E. Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29:iv238–55.
Article CAS PubMed Google Scholar
Moctezuma-Velázquez C, Lewis S, Lee K, Amodeo S, Llovet JM, Schwartz M, et al. Non-invasive imaging criteria for the diagnosis of hepatocellular carcinoma in non-cirrhotic patients with chronic hepatitis B. JHEP Rep. 2021;3(6):100364.
Article PubMed PubMed Central Google Scholar
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
Article PubMed PubMed Central Google Scholar
Tam WWS, Tang A, Woo B, Goh SYS. Perception of the preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement of authors publishing reviews in nursing journals: a cross-sectional online survey. BMJ Open. 2019;9(4):e026271.
Article PubMed PubMed Central Google Scholar
Nawijn F, Ham WHW, Houwert RM, Groenwold RHH, Hietbrink F, Smeeing DPJ. Quality of reporting of systematic reviews and meta-analyses in emergency medicine based on the PRISMA statement. BMC Emerg Med. 2019;19(1):19.
Article PubMed PubMed Central Google Scholar
Page MJ, Moher D. Evaluations of the uptake and impact of the preferred reporting items for systematic reviews and Meta-Analyses (PRISMA) statement and extensions: a scoping review. Syst Rev. 2017;6(1):263.
Article PubMed PubMed Central Google Scholar
Ravaud P, Créquit P, Williams HC, Meerpohl J, Craig JC, Boutron I. Future of evidence ecosystem series: 3. From an evidence synthesis ecosystem to an evidence ecosystem. J Clin Epidemiol. 2020;123:153–61.
留言 (0)